What Is Addyi? The Controversy Behind the Drug Nicknamed the ‘Female Viagra’
Marketed as a breakthrough for low libido in women, flibanserin’s approval followed two FDA rejections, a controversial campaign, and safety concerns
Jun 6, 2025Marketed as a breakthrough for low libido in women, flibanserin’s approval followed two FDA rejections, a controversial campaign, and safety concerns
Jun 6, 2025During RFK Jr.'s confirmation hearing, both he and senators questioning him implied that the FDA was actively avoiding studying the side effects of mifepristone. That’s not true.
Feb 18, 2025Scott Frenzel had been treated at his local healthcare clinic in Nashville, Tennessee, for a sexually transmitted infection (STI) twice. Even though he is a prime candidate for pre-exposure prophylaxis (PrEP), a drug that can…
Aug 23, 2023The “morning-after pill” is available to a second generation at Jennifer’s home. “I have three teenagers, two boys and a girl, in the house,” she says, explaining that she keeps My Way (levonorgestrel) on hand.
Jun 22, 2022Veda has used both the so-called abortion pill and a dilation and curettage (D&C) procedure to end two separate pregnancies. When she was 20, the now 27-year-old mother of a healthy toddler went to a…
May 26, 2022It’s been 16 years since the first vaccine designed to prevent cervical cancer received approval from the Food and Drug Administration (FDA). The human papillomavirus (HPV) vaccine was first approved and recommended for females who…
Mar 31, 2022I started taking the pill when I was in college, not as a method of birth control, but because it was the only thing that worked to quell the debilitating symptoms –- agonizing cramps, headaches,…
Sep 24, 2020Help fund our fight for improved medication safety and transparency by supporting our independent journalism.
Give NowNo pharma ads. No political bias. Just straight up strong journalism.
Delivered directly to your inbox.
We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.
We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.
As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.